An Experimental Model of Prolonged Esophagitis With Sphincter Failure in the Rat and the Therapeutic Potential of Gastric Pentadecapeptide BPC 157

An Experimental Model of Prolonged Esophagitis With Sphincter Failure in the Rat and the Therapeutic Potential of Gastric Pentadecapeptide BPC 157

We report a simple novel rat model that combines prolonged esophagitis and parallel sphincters failure. The anti-ulcer gastric pentadecapeptide BPC 157, which was found to be stable in gastric juice, and is being evaluated in inflammatory bowel disease trials, is an antiesophagitis therapy that reco...

Full description

Bibliographic Details
Main Authors:	Igor Petrovic, Ivan Dobric, Petar Drvis, Drazen Shejbal, Luka Brcic, Alenka Boban Blagaic, Lovorka Batelja, Neven Kokic, Ante Tonkic, Stjepan Mise, Tomislav Baotic, Mario Staresinic, Bozo Radic, Ana Jakir, Tihomir Vuksic, Tomislav Anic, Sven Seiwerth, Predrag Sikiric
Format:	Article
Language:	English
Published:	Elsevier 2006-01-01
Series:	Journal of Pharmacological Sciences
Online Access:	http://www.sciencedirect.com/science/article/pii/S1347861319343695

Similar Items

Prolonged Esophagitis After Primary Dysfunction of the Pyloric Sphincter in the Rat and Therapeutic Potential of the Gastric Pentadecapeptide BPC 157
by: Ivan Dobric, et al.
Published: (2007-01-01)

Stable Gastric Pentadecapeptide BPC 157 and Wound Healing
by: Sven Seiwerth, et al.
Published: (2021-06-01)

Stable Gastric Pentadecapeptide BPC 157 and Striated, Smooth, and Heart Muscle
by: Mario Staresinic, et al.
Published: (2022-12-01)

Stable Gastric Pentadecapeptide BPC 157 as a Therapy for the Disable Myotendinous Junctions in Rats
by: Mladen Japjec, et al.
Published: (2021-10-01)

The effect of pentadecapeptide BPC 157 on hippocampal ischemia/reperfusion injuries in rats
by: Jakša Vukojević, et al.
Published: (2020-08-01)

The Stable Gastric Pentadecapeptide BPC 157 Pleiotropic Beneficial Activity and Its Possible Relations with Neurotransmitter Activity
by: Predrag Sikiric, et al.
Published: (2024-04-01)

Stable Gastric Pentadecapeptide BPC 157 Therapy of Rat Glaucoma
by: Tamara Kralj, et al.
Published: (2021-12-01)

Stable Gastric Pentadecapeptide BPC 157 and Intestinal Anastomoses Therapy in Rats—A Review
by: Salem Bajramagic, et al.
Published: (2024-08-01)

Pentadecapeptide BPC 157, in Clinical Trials as a Therapy for Inflammatory Bowel Disease (PL14736), Is Effective in the Healing of Colocutaneous Fistulas in Rats: Role of the Nitric Oxide-System
by: Robert Klicek, et al.
Published: (2008-01-01)

Stable Gastric Pentadecapeptide BPC 157 Therapy for Monocrotaline-Induced Pulmonary Hypertension in Rats Leads to Prevention and Reversal
by: Mario Udovicic, et al.
Published: (2021-07-01)

Doxorubicine-Congestive Heart Failure-Increased Big Endothelin-1 Plasma Concentration: Reversal by Amlodipine, Losartan, and Gastric Pentadecapeptide BPC157 in Rat and Mouse
by: Martina Lovric-Bencic, et al.
Published: (2004-01-01)

Corrigendum: Stable Gastric Pentadecapeptide BPC 157 Therapy for Primary Abdominal Compartment Syndrome in Rats
by: Marijan Tepes, et al.
Published: (2022-01-01)

Stable Gastric Pentadecapeptide BPC 157 May Recover Brain–Gut Axis and Gut–Brain Axis Function
by: Predrag Sikiric, et al.
Published: (2023-04-01)

Stable Gastric Pentadecapeptide BPC 157 as Therapy After Surgical Detachment of the Quadriceps Muscle from Its Attachments for Muscle-to-Bone Reattachment in Rats
by: Danijel Matek, et al.
Published: (2025-01-01)

Stable Gastric Pentadecapeptide BPC 157—Possible Novel Therapy of Glaucoma and Other Ocular Conditions
by: Predrag Sikiric, et al.
Published: (2023-07-01)

Stable Gastric Pentadecapeptide BPC 157 Heals Established Vesicovaginal Fistula and Counteracts Stone Formation in Rats
by: Domagoj Rasic, et al.
Published: (2021-09-01)

Antiarrhythmic Sotalol, Occlusion/Occlusion-like Syndrome in Rats, and Stable Gastric Pentadecapeptide BPC 157 Therapy
by: Ivica Premuzic Mestrovic, et al.
Published: (2023-07-01)

Stable Gastric Pentadecapeptide BPC 157 Therapy: Effect on Reperfusion Following Maintained Intra-Abdominal Hypertension (Grade III and IV) in Rats
by: Marijan Tepes, et al.
Published: (2023-11-01)

Occluded Superior Mesenteric Artery and Vein. Therapy with the Stable Gastric Pentadecapeptide BPC 157
by: Mario Knezevic, et al.
Published: (2021-07-01)

Pentadecapeptide BPC 157 as Therapy for Inferior Caval Vein Embolization: Recovery of Sodium Laurate-Post-Embolization Syndrome in Rats
by: Ivan Maria Smoday, et al.
Published: (2023-10-01)

Pentadecapeptide BPC 157 and the central nervous system
by: Jakša Vukojevic, et al.
Published: (2022-01-01)

Over-Dose Lithium Toxicity as an Occlusive-like Syndrome in Rats and Gastric Pentadecapeptide BPC 157
by: Sanja Strbe, et al.
Published: (2021-10-01)

Stable Gastric Pentadecapeptide BPC 157 May Counteract Myocardial Infarction Induced by Isoprenaline in Rats
by: Ivan Barisic, et al.
Published: (2022-01-01)

Robert’s Intragastric Alcohol-Induced Gastric Lesion Model as an Escalated General Peripheral and Central Syndrome, Counteracted by the Stable Gastric Pentadecapeptide BPC 157
by: Slaven Gojkovic, et al.
Published: (2021-09-01)

Novel Therapeutic Effects in Rat Spinal Cord Injuries: Recovery of the Definitive and Early Spinal Cord Injury by the Administration of Pentadecapeptide BPC 157 Therapy
by: Darko Perovic, et al.
Published: (2022-04-01)

In relation to NO-System, Stable Pentadecapeptide BPC 157 Counteracts Lidocaine-Induced Adverse Effects in Rats and Depolarisation In Vitro
by: Marin Lozic, et al.
Published: (2020-01-01)

Stable Gastric Pentadecapeptide BPC 157, Robert’s Stomach Cytoprotection/Adaptive Cytoprotection/Organoprotection, and Selye’s Stress Coping Response: Progress, Achievements, and the Future
by: Predrag Sikiric, et al.
Published: (2020-03-01)

Fourier Transform Infrared Spectroscopy Reveals Molecular Changes in Blood Vessels of Rats Treated with Pentadecapeptide BPC 157
by: Ozren Gamulin, et al.
Published: (2022-12-01)

Innate Vascular Failure by Application of Neuroleptics, Amphetamine, and Domperidone Rapidly Induced Severe Occlusion/Occlusion-like Syndromes in Rats and Stable Gastric Pentadecapeptide BPC 157 as Therapy
by: Sanja Strbe, et al.
Published: (2023-05-01)

Pentadecapeptide BPC 157 Shortens Duration of Tetracaine- and Oxybuprocaine-Induced Corneal Anesthesia in Rats
by: Ivan Mirković, et al.
Published: (2020-01-01)

Pentadecapeptide BPC 157 Reduces Bleeding and Thrombocytopenia after Amputation in Rats Treated with Heparin, Warfarin, L-NAME and L-Arginine.
by: Mirjana Stupnisek, et al.
Published: (2015-01-01)

Effect of Pentadecapeptide BPC 157 on Hypercalcaemia in Rats
by: Matej Lacković, et al.
Published: (2023-01-01)

Complex Syndrome of the Complete Occlusion of the End of the Superior Mesenteric Vein, Opposed with the Stable Gastric Pentadecapeptide BPC 157 in Rats
by: Mario Knezevic, et al.
Published: (2021-08-01)

Stable Gastric Pentadecapeptide BPC 157 as Useful Cytoprotective Peptide Therapy in the Heart Disturbances, Myocardial Infarction, Heart Failure, Pulmonary Hypertension, Arrhythmias, and Thrombosis Presentation
by: Predrag Sikiric, et al.
Published: (2022-10-01)

Therapy Effect of the Stable Gastric Pentadecapeptide BPC 157 on Acute Pancreatitis as Vascular Failure-Induced Severe Peripheral and Central Syndrome in Rats
by: Ivan Maria Smoday, et al.
Published: (2022-06-01)

Stable gastric pentadecapeptide BPC 157 can improve the healing course of spinal cord injury and lead to functional recovery in rats
by: Darko Perovic, et al.
Published: (2019-07-01)

BPC 157 as a Therapy for Retinal Ischemia Induced by Retrobulbar Application of L-NAME in Rats
by: Mirna Zlatar, et al.
Published: (2021-06-01)

Molecular effects of stable gastric pentadecapeptide BPC 157 on psoriasis
by: Hrvoje Vraneš, et al.
Published: (2023-01-01)

PENTADECAPEPTIDE BPC 157 RESOLVES TOURNIQUET INDUCED ISCHEMIAREPERFUSION INJURY
by: Katarina Oroz, et al.
Published: (2023-01-01)

The effects of pentadecapeptide BPC 157 on the healing of the incisional skin wound in rats
by: Luka Kalogjera, et al.
Published: (2023-01-01)